Perioral Dermatitis

Understanding Perioral Dermatitis: A Comprehensive Guide

Perioral dermatitis, also known as periorificial dermatitis, is a common skin condition that manifests as a rash primarily around the mouth and nostrils. It can also involve less commonly affected areas such as the eyes and genitalia. Although often confused with other dermatological issues like rosacea or acne, perioral dermatitis is distinct in its presentation and treatment.

What is Perioral Dermatitis?

Perioral dermatitis is characterized by the appearance of numerous small papules (bumps) and pustules (blisters), often accompanied by background redness and scaling. These symptoms are localized around the mouth and nostrils, and occasionally extend to the eyes and genital area. One defining feature is the sparing of the vermillion border, the line where the lip meets the surrounding skin, which remains unaffected.

This condition can be persistent or recurrent and shares similarities with rosacea and acne, but is not an eczematous process, despite being termed “dermatitis.”

Causes and Risk Factors

The exact cause of perioral dermatitis remains unclear. However, several factors are associated with its development:

1. Topical Steroids: Prolonged use of topical steroids is strongly linked to the onset of perioral dermatitis. The condition often emerges as a reaction to these medications, although stopping them can initially worsen the rash.
2. Cosmetics and Moisturizers: Frequent application of cosmetics, especially those containing moisturizing agents or heavy formulations, can exacerbate the condition by irritating the skin and occluding hair follicles.
3. Fluoridated Toothpaste: Some studies suggest that toothpaste containing fluoride might worsen perioral dermatitis, although the exact mechanism remains uncertain.
4. Micro-organisms: Increased growth of skin flora due to blocked skin surfaces might contribute to the condition. Potentially relevant micro-organisms include Candida species, Demodex folliculorum, and fusobacteria.
5. Other Factors: Reports have suggested that factors like the wearing of veils and certain types of ultraviolet therapy might play a role in worsening the condition.

Signs and Symptoms

Perioral dermatitis typically presents with:

• Papules and Pustules: Small, red bumps and blisters primarily around the mouth and nose.
• Background Redness: A reddish hue of the affected skin.
• Sparing of Vermillion Border: The skin directly adjacent to the lips remains unaffected.
• Burning Sensation: A stinging or burning sensation in the affected area, with itching being less common.

This rash can also cause emotional distress, with some patients reporting depression and anxiety associated with the visible symptoms.

Diagnosis

Diagnosing perioral dermatitis generally involves assessing the rash’s appearance and characteristics. Although a skin biopsy is not usually necessary, it can help rule out other similar conditions such as rosacea, acne, or allergic contact dermatitis. Extended patch testing may be used to exclude allergic causes.

Treatment and Management

Managing perioral dermatitis typically involves several approaches:

1. Discontinuation of Topical Steroids: The most crucial step is to stop using topical steroids, though this may initially exacerbate the condition.
2. Avoiding Irritants: Limiting the use of irritating products, including strong cosmetic agents and certain moisturizers, can help prevent flare-ups.
3. Medications: In more severe cases, oral antibiotics such as tetracycline, doxycycline, and erythromycin may be prescribed. Tetracycline is often used at 250 to 500 mg twice daily, while doxycycline is usually given at 100 mg daily. Erythromycin can be used as an alternative if tetracyclines are not suitable. Metronidazole gel can be applied topically, and pimecrolimus cream might be effective for steroid-induced cases.
4. Zero Treatment: This approach involves stopping all irritants and allowing the skin to heal without additional medication.

Prognosis

With appropriate treatment, perioral dermatitis generally resolves within a few months. However, if left untreated, it can persist for years and take a chronic form. Most patients experience significant improvement within a few weeks of starting antibiotic treatment.

Epidemiology

Perioral dermatitis affects approximately 0.5-1% of people annually in developed countries. It is most common in women aged 16 to 45 years but can also affect children and the elderly. Recent reports indicate an increasing incidence in men.

Conclusion

Perioral dermatitis is a complex condition with various contributing factors and treatment options. Understanding its characteristics and triggers is crucial for effective management and resolution. If you suspect you have perioral dermatitis, consulting a dermatologist for an accurate diagnosis and appropriate treatment plan is essential.

---

References:

1. Tempark T, Shwayder TA (April 2014). “Perioral dermatitis: a review of the condition with special attention to treatment options”. American Journal of Clinical Dermatology. 15 (2): 101–113.
2. Goldsmith LP, Katz SI, Gilchrest BA, Paller AS (2012). “Chapter 82: Perioral dermatitis”. Fitzpatrick’s Dermatology in General Medicine (8th ed.). The McGraw-Hill Companies. pp. 926–928.
3. Du Vivier A (2013). Atlas of Clinical Dermatology (4th ed.). Elsevier Saunders. pp. 609–610.
4. Patterson JW (2019). “8. The granulomatous reaction pattern”. Weedon’s Skin Pathology (5th ed.). Elsevier Health Sciences. p. 219.
5. Hall CS, Reichenberg J (August 2010). “Evidence based review of perioral dermatitis therapy”. Giornale Italiano di Dermatologia e Venereologia. 145 (4): 433–444.
6. Kammler HJ, Zaenglein AL (November 2020). Talavera F, James WD (eds.). “Perioral Dermatitis: Background, Pathophysiology, Epidemiology”. Medscape. WebMD LLC.
7. Habif TP (2009). “7. Acne, Rosacea, and Related Disorders”. Clinical Dermatology (5th ed.). Mosby, Elsevier. pp. 253–255.
8. Lee GL, Zirwas MJ (July 2015). “Granulomatous Rosacea and Periorificial Dermatitis: Controversies and Review of Management and Treatment”. Dermatologic Clinics. 33 (3): 447–455.
9. Marks R (2007). “Chapter 3: Perioral dermatitis and miscellaneous inflammatory disorders of unknown origin”. Facial Skin Disorders. CRC Press. pp. 32–39.
10. “Peter Edward Darrell Sheldon Wilkinson”. Munk’s Roll. London: Heritage Centre, Royal College of Physicians.
11. Layton AM, Eady EE, Zouboulis CC (2016). “Chapter 90: Acne”. In Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D (eds.). Rook’s Textbook of Dermatology (Ninth ed.). Chichester, West Sussex: John Wiley & Sons.
12. Powell FC (2016). “Chapter 91: Rosacea”. In Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D (eds.). Rook’s Textbook of Dermatology (Ninth ed.). Chichester, West Sussex: John Wiley & Sons.
13. Searle T, Ali FR, Al-Niaimi F (December 2021). “Perioral dermatitis: Diagnosis, proposed etiologies, and management”. Journal of Cosmetic Dermatology. 20 (12): 3839–3848.
14. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson IH (2018). Treatment of Skin Disease: Comprehensive Therapeutic Strategies (5th ed.). Elsevier. pp. 619–620.
15. “ICD-11 Beta Draft – Mortality and Morbidity Statistics”. icd.who.int.
16. “ICD-11 Beta Draft – Mortality and Morbidity Statistics”. icd.who.int.
17. Oakley A (2016). “Periorificial dermatitis”. DermNet. New Zealand.
18. “Perioral dermatitis”. Medline Plus. U.S. National Library of Medicine.
19. Swenson K, Stern A, Graber E (June 2024). “A Retrospective Review of a Cohort of Patients with Periorificial Dermatitis Treated with Sarecycline”. The Journal of Clinical and Aesthetic Dermatology. 17 (6): 50–54.
20. Gray NA, Tod B, Rohwer A, Fincham L, Visser WI, McCaul M (March 2022). “Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: a systematic review”. Journal of the European Academy of Dermatology and Venereology. 36 (3): 380–390.